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Summary
Introduction:  Cancer  of  the  external  auditory  canal  is  a  rare  tumour  with  an  annual  incidence
of one  per  one  million  inhabitants.  The  objective  of  this  study  was  to  evaluate  the  5-year  overall
survival and  disease-free  survival  rates  in  a  series  of  patients  with  carcinoma  of  the  external
auditory canal  and  to  compare  our  results  concerning  the  clinical  presentation,  management
and survival  with  those  of  the  literature.
Patients  and  method:  Ten  patients  were  included  in  this  retrospective,  single-centre  study  over
a 20-year  period.  Data  concerning  age,  symptoms,  imaging,  TNM  stage  according  to  the  Pitts-
burgh classiﬁcation,  histology,  management,  sequelae,  recurrences  and  survival  were  recorded.
Results:  The  mean  age  of  the  patients  of  this  series  was  60.7  years.  Seven  patients  had  a  squa-
mous cell  carcinoma.  The  other  histological  types  were  undifferentiated  carcinoma,  adenoid
cystic carcinoma  and  neuroendocrine  carcinoma.  Staging  was  based  on  the  Pittsburgh  classiﬁ-
cation with  one  stage  I,  one  stage  III  and  eight  stage  IV  tumours.  Five-year  overall  survival  rates
were 100%,  50%  and  0%,  respectively.  The  mean  5-year  overall  survival  rate  was  35%  and  the
mean 5-year  disease-free  survival  rate  was  24%.
Conclusion:  Carcinoma  of  the  external  auditory  canal  is  a  difﬁcult  diagnosis  when  the  tumour
does not  present  as  a  fungating  mass  protruding  from  the  external  auditory  canal.  The  Pittsburgh
classiﬁcation  was  used  for  TNM  staging  of  these  tumours,  allowing  comparison  of  our  results
with those  of  the  literature.  The  clinical  ﬁndings  and  survival  rates  observed  in  this  study  are
comparable  to  those  reported  in  the  literature.  These  tumours  are  associated  with  a  poor
prognosis  on  the  basis  of  our  results  and  published  data.
.  All  
O© 2013  Elsevier  Masson  SAS
IntroductionCancer  of  the  external  auditory  canal  (EAC)  is  a  rare  tumour,
representing  less  than  0.2%  of  all  head  and  neck  cancers  [1].
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nly  4%  of  cancers  of  the  outer  ear  are  conﬁned  to  the  EAC.
he  annual  incidence  of  carcinoma  of  the  EAC  is  estimated
o  be  between  one  to  six  per  million  inhabitants  [2]  and
he  prevalence  is  one  per  million  inhabitants  [3,4], which
xplains  the  small  sample  sizes  of  the  series  published  in
he  literature.These  tumours  must  be  diagnosed  at  an  early  stage  to
void  the  mutilating  surgery  required  at  advanced  stages.
toscopy  usually  allows  easy  diagnosis  of  these  tumours  by
roviding  direct  vision  of  the  lesion.  In  clinical  practice,  the
served.
1 K.  Ouaz  et  al.
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Table  1  University  of  Pittsburgh  TNM  staging  system  for
carcinomas  of  the  external  auditory  canal  (EAC)  [1,6].
T
T1:  tumour  limited  to  the  EAC  without  bony  erosion  or
evidence  of  soft  tissue  involvement
T2:  tumour  with  limited  external  auditory  canal  bone
erosion  (not  full  thickness)  or  limited  (<  0.5  cm)  soft
tissue  involvement
T3:  tumour  eroding  the  osseous  bone  EAC  (full
thickness)  with  limited  (<  0.5  cm)  soft  tissue
involvement  or  tumour  involving  the  middle  ear
and/or  mastoid
T4:  tumour  eroding  the  cochlea,  petrous  apex,  medial
wall  of  the  middle  ear,  carotid  canal,  jugular
foramen,  or  dura,  or  with  extensive  soft  tissue
involvement  (>  0.5  cm),  or  evidence  of  facial  paresis
N
N0: no  regional  lymph  node  metastasis
N1:  a  single  regional  metastatic  lymph  node  <  3  cm
N2a:  a  single  ipsilateral  metastatic  lymph  node
measuring  3—6  cm
N2b:  several  ipsilateral  metastatic  lymph  nodes  <  6  cm
N2c: contralateral  metastatic  lymph  node
N3: metastatic  lymph  node  >  6  cm
M:  distant  metastasis
Stages
Stage  I
Stage  II
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esion  is  usually  superinfected,  invasive  and  can  be  confused
ith  chronic  otitis  externa  [5].  When  the  lesion  is  not  cor-
ectly  diagnosed,  it  can  spread  locally  to  the  middle  ear
nd  invade  vital  structures  present  in  the  temporal  bone
internal  carotid  artery,  facial  canal,  cochlea,  vestibule).
There  is  no  consensus  at  the  present  time  concerning
NM  staging  of  these  tumours  by  the  Union  Internationale
ontre  Le  Cancer  (UICC)  or  the  American  Joint  Committee  on
ancer  (AJCC).  However,  since  the  beginning  of  the  1990s,
he  Pittsburgh  radioclinical  classiﬁcation  of  carcinoma  of
he  EAC  [6]  has  become  widely  used  in  the  international
iterature  and  has  been  demonstrated  to  be  reliable  and
eproducible  [1,7].
The  reference  treatment  for  cancer  of  the  EAC  is  surgery
8],  which  is  often  mutilating  due  to  the  anatomical  site
f  these  tumours.  These  operations  were  reputed  to  be
ssociated  with  severe  postoperative  morbidity.  However,
rogress  in  general  anaesthesia,  aseptic  techniques  and
ntensive  care  has  allowed  an  improvement  of  postoperative
urvival  following  radical  surgical  procedures.  The  progress
rovided  by  new  technologies,  such  as  surgical  navigation
nd  intraoperative  facial  nerve  monitoring,  have  allowed  an
mprovement  of  the  quality  of  otological  tumour  resection
nd  improvement  of  the  patient’s  quality  of  life  by  reduc-
ng  the  risks  of  sequelae.  Despite  these  improvements,
dvanced  tumours  (stages  III—IV)  are  associated  with  a  poor
rognosis  with  low  disease-free  survival  and  overall  survival
ates.
The  most  common  histological  type  of  carcinoma  of  the
AC  is  squamous  cell  carcinoma.  The  other  histological
ypes  are  basal  cell  carcinoma,  malignant  melanoma,  Merkel
ell  carcinoma,  angiosarcoma,  adnexal  carcinoma,  including
eruminous  adenocarcinoma  and  adenoid  cystic  carcinoma,
nd  lymphoma  [9].  The  prognosis  depends  on  the  histological
ype  [9].
The  primary  objective  of  this  study  was  to  evaluate  the
verall  survival  and  disease-free  survival  rates  of  patients
ith  a  malignant  tumour  of  the  external  auditory  canal  with
etastatic  potential.  The  results  of  this  study  are  discussed
n  the  light  of  the  literature.
atients and  methods
his  retrospective,  single-centre  study  was  based  on  review
f  the  medical  charts  of  a  consecutive  series  of  patients  with
 malignant  tumour  of  the  EAC  managed  between  1991  and
011  in  our  otorhinolaryngology  department.
Clinical  data  concerning  age,  gender,  otological  history,
ate  and  mode  of  diagnosis,  site,  histological  type,  manage-
ent,  and  survival  were  recorded  for  each  patient  included.
he  date  of  diagnosis  corresponded  to  the  date  of  the  ﬁrst
iopsy  that  conﬁrmed  the  malignant  nature  of  the  lesion.
umour  site,  lymph  node  status  (cervical  and  parotid)  and
he  presence  of  metastases  were  determined  from  clini-
al  ﬁndings,  computed  tomography  (CT)  and/or  magnetic
esonance  imaging  (MRI)  imaging  and  the  operation  report.
umour  stage  was  established  according  to  the  university  of
ittsburgh  Tumor,  Node  and  Metastasis  (TNM)  classiﬁcation
or  squamous  cell  carcinomas  of  the  EAC  [1,8]  (Table  1).
The  type  of  therapeutic  management  and  the  length  of
ostoperative  hospital  stay  in  surgically  treated  patients
r
f
w
aStage  III
Stage  IV:  T4N0  or  T  ×  N+
ere  recorded.  The  histology  reports  for  the  operative
pecimens  indicated  the  surgical  margins,  revised  surgical
argins,  bone  and  cartilage  invasion  and  the  presence  of
ymph  node  invasion  on  lymph  node  dissection  specimens.
Each  case  was  discussed  at  a  multidisciplinary  consul-
ation  meeting.  Surgical  resection  was  systematically
roposed  except  for  locally  advanced  tumours  with  exten-
ion  to  the  posterior  cranial  fossa,  internal  carotid  artery  or
iddle  cranial  fossa,  in  the  presence  of  contraindications  to
eneral  anaesthesia  related  to  comorbidities  or  in  the  case
f  metastatic  disease.  Adjuvant  radiotherapy  was  system-
tically  proposed  after  surgical  resection.  Chemotherapy
as  considered  in  cases  with  positive  surgical  margins,  local
ecurrence  or  distant  metastases.
Post-treatment  sequelae  (peripheral  facial  nerve  palsy,
ensorineural  hearing  loss)  and  cosmetic  sequelae  (poor
ealing,  amputation  of  the  outer  ear)  were  also  recorded.
he  5-year  overall  survival  and  disease-free  survival  rates
ere  evaluated  according  to  the  Kaplan—Meier  method.
esults
en  patients  with  a  mean  age  of  60.7  years  (±7.2)  and  a  sex
atio  of  1  were  included.  Two  patients  had  been  followed
or  cholesteatoma.  The  presenting  symptoms  and  signs
ere  non-speciﬁc.  Six  (60%)  patients  reported  otorrhoea
nd  three  of  them  (30%)  had  been  followed  for  persistent
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Table  2  Clinical  ﬁndings,  TNM  stage  and  therapeutic  management  of  the  10  patients  of  this  series.
#  Age  Gender  Symptoms  FNP  Otoscopy  Histo  Pittsburgh
TNM
pTNM  Stage  Treatment  Follow-up  (months)  Status
1  61  M  Otalgia  N
 
 
 
SCC  T4N0M0  —  IV  —  0  D
2 69  M  Otorrhoea
Loss  of
balance
Y  SCC  T4N0M0  T4N0M0  IV  TP
EBR
7  D
3 55  M  Otalgia
Otorrhoea
N  SCC  T4N0M0  T4N0M0  IV  PP
EBR
CT
10  D
4 57  F  None  Y  NEC  T4N0M0  T4N1M0  IV  PP  +  OER  +  NPD
CT
10  D
5 65  F  Otalgia
Otorrhoea
N  SCC  T4N0M0  T4N0M0  IV  EBR
CT
17  D
6 70  F  Otorrhoea
Bleeding
N  SCC  T3N1M0  T3N1M0  IV  EACR  +  NPD
EBR
113  D
7 67  M  Otorrhoea  N  SCC  T4N0M0  T4N0M0  IV  PP  +  OER  +  NPD
EBR
4  A
8 52  M  Bleeding
Otorrhoea
N  SCC  T4N0M0  T4N0M0  IV  TP  +  OER  +  NPD
EBR  +  CT
12  A
9 62  F  Pruritus  N  SCC  T3N0M0  T3N0M0  III  PP  +  OER  +  NPD
EBR
7  A
10 49  F  Unknown  N  ACC  T1N0M0  T1N0M0  I  EACR  +  NPD
EBR
62  A
FNP: facial nerve palsy; Histo: histopathology; SCC: squamous cell carcinoma; ACC: adenoid cystic carcinoma; NEC: neuroendocrine
carcinoma; TP: total petrectomy; PP: partial petrectomy; EBR: external beam radiotherapy; CT: chemotherapy; EACR: EAC resection;
OER: outer ear resection; NPD: neck and parotid dissection; A: alive; D: dead; N: no; Y: yes.
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(otitis  externa  (#  2,  #  5,  #  6)  for  more  1  year.  Three  patients
complained  of  otalgia  (30%  of  cases)  (#  1,  #  3,  #  5),  and  two
reported  bleeding  from  the  external  auditory  canal  (20%)
(#  6,  #  8).  One  patient  (#  2)  complained  of  loss  of  balance
(10%)  and  another  patient  reported  pruritus  of  the  external
auditory  canal  (10%)  (#  9).  The  mean  interval  between
onset  of  the  ﬁrst  symptoms  and  diagnosis  was  10  months
(±8)  with  a  mean  interval  of  14  months  for  patients  with  a
stage  IV  tumour  (±8).
Otoscopic  ﬁndings  are  presented  in  Table  2. Otoscopy
revealed  a  fungating  tumour  in  seven  cases  and  an  invasive
d
(
numour  of  the  EAC  in  three  cases  (#  3,  #  5,  #  8).  Complete
eripheral  facial  nerve  palsy  was  present  in  two  patients
20%)  (#  2,  #  4).  Extension  to  the  outer  ear  was  reported  for
hree  patients  (#  4,  #  7,  #  9)  (30%).  Pretreatment  audiom-
try  demonstrated  profound  deafness  in  two  patients  (20%)
#  2,  #  7).  Three  patients  (30%)  presented  mixed  hearing  loss
#  1,  #  3,  #  8)  on  the  side  of  the  tumour.  Five  patients  (50%)
id  not  present  any  audiometric  signs  related  to  the  tumour
#  4,  #  5,  #  6,  #  9,  #  10).
Histological  examination  revealed  squamous  cell  carci-
oma  for  seven  patients  (70%)  (Fig.  1),  while  the  other
178  K.  Ouaz  et  al.
Figure  1  Imaging  assessment  (CT  and  MRI),  operative  specimen  and  histology  of  a  patient  (#  7)  with  squamous  cell  carcinoma  of
the right  external  auditory  canal.  A.  CT  scan  of  petrous  temporal  bones,  coronal  reconstruction  showing  middle  ear  and  facial  canal
involvement  (*).  CSCL:  lateral  semicircular  canal.  B.  MRI,  axial  T1-weighted  sequence  showing  tumour  extension  to  subcutaneous
soft tissues  and  erosion  (*)  of  the  anterior  wall  of  the  right  external  auditory  canal.  FIT:  infratemporal  fossa;  ATM:  temporomandibu-
lar joint;  MAE:  external  auditory  canal.  C.  Operative  specimen  with  en  bloc  resection  of  the  outer  ear,  external  auditory  canal
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wcartilaginous and  bony)  and  tympanic  membrane.  D.  Histologic
uditory canal  (magniﬁcation  ×  10).
istological  types  were  undifferentiated  carcinoma  (10%),
denoid  cystic  carcinoma  (10%)  and  a  neuroendocrine  carci-
oma  comprising  skin  cells  (10%).
CT  scan  of  the  petrous  temporal  bones  and  CT  scans
ooking  for  lymph  node  and  lung  metastases  were  system-
tically  performed.  Head  and  neck  MRI  was  performed  in
ix  patients.  Imaging  assessment  demonstrated  invasion  of
he  tympanic  cavity  and  mastoid  in  six  patients  (60%),  ero-
ion  of  the  EAC  in  ﬁve  cases  (50%),  suspected  invasion  of
he  temporal  dura  mater  in  four  cases  (40%),  invasion  of
he  facial  canal  in  four  cases  (40%),  parotid  gland  involve-
ent  in  four  cases  (40%),  erosion  of  the  lateral  semicircular
anal  in  three  cases  (30%),  erosion  of  the  atlas  in  one  case
10%)  and  extension  to  the  temporal  lobe  in  one  case  (10%).
etastatic  cervical  lymphadenopathy  was  demonstrated  in
ne  patient  (10%).  No  metastatic  disease  was  detected  prior
o  treatment.
The  TNM  stage  was  determined  on  the  basis  of  this  pre-
reatment  clinical  and  radiological  work-up  according  to
he  Pittsburgh  classiﬁcation,  revealing  six  stage  T4  tumours
60%),  three  stage  T3  tumours  (30%)  and  one  stage  T1  tumour
10%).  Only  one  patient  was  classiﬁed  as  N1.  The  tumour  was
d
t
m
Tction  (HES  stain)  of  a  squamous  cell  carcinoma  of  the  external
lassiﬁed  as  stage  IV  for  eight  patients  (80%),  stage  III  for  one
atient  (10%)  and  stage  I for  another  patient  (10%).
Two  patients  were  not  treated  surgically.  One  patient
ied  from  pulmonary  embolism  before  starting  treatment
#  1)  and  the  other  patient  presented  deterioration  of
is  general  status  associated  with  intracerebral  extension
xcluding  surgical  control  of  the  cancer  (#  5).
Eight  patients  (80%)  were  treated  surgically,  by  total  or
ubtotal  petrectomy  with  resection  of  the  dura  mater  in  two
ases  (25%  of  operated  patients)  (#  2,  #  8)  and  partial  petrec-
omy  in  four  cases  (50%  of  operated  patients)  (#  3,  #  4,  #  7,  #
).  Two  patients  (25%  of  operated  patients)  (#  7,  #  10)  under-
ent  radical  resection  of  the  EAC  and  the  vertical  segment
f  the  facial  nerve  was  resected  in  two  cases  (25%  of  oper-
ted  patients)  (#  2,  #  4).  Surgical  resection  removed  all  of
he  outer  ear  in  three  patients  (46.9%  of  operated  patients)
#  4,  #  7,  #  8)  (Fig.  1),  while  partial  resection  of  the  outer  ear
as  necessary  in  another  case  (#  9).  Reconstruction  of  the
efect  after  total  amputation  of  the  outer  ear  used  a  pec-
oralis  major  ﬂap  in  two  cases  (#  7,  #  8)  and  a temporalis
uscle  ﬂap  with  secondary  healing  in  the  other  case  (#  4).
umour  resection  was  complete  (negative  surgical  margins)
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iFigure  2  Five-year  disease-free  survival  and  overall  survival
(EAC). A.  Five-year  disease-free  survival  rate.  B.  Five-year  overa
in  ﬁve  patients  (62.5%  of  operated  patients)  (and  positive
margins  were  reported  for  three  patients)  with  positive  sur-
gical  margins  for  three  patients  (37.5%  of  operated  patients)
(#  4,  #  7,  #  8).
Neck  and  parotid  dissection  was  performed  in  six  cases
and  a  modiﬁed  radical  neck  and  parotid  dissection  (with
resection  of  the  sternocleidomastoid  muscle  and  internal
jugular  vein)  was  performed  in  one  case  (#  6).  Histological
examination  revealed  lymph  node  invasion  in  two  patients
(#  4  and  #  6),  i.e.  33%  of  the  patients  in  whom  lymph
node  dissection  was  performed.  Selective  neck  dissection
was  performed  in  patient  #  2  in  a  context  of  ipsilateral
metastatic  level  V  lymph  node  involvement  4  months  after
the  initial  resection.  The  mean  length  of  postoperative  hos-
pital  stay  was  22.3  days  (±16.7).
Radiotherapy  was  performed  in  eight  cases  (80%).  Radio-
therapy  was  not  performed  in  two  cases:  one  patient  died
before  treatment  (#  1)  and  one  patient  developed  lung
metastases  before  healing  (#  4).  Radiotherapy  consisted  of
conventional  radiotherapy  to  the  tumour  bed  and  lymph
node  areas  with  a  prophylactic  dose  of  40—55  Gy  and  a
curative  dose  of  66—75  Gy  and  corresponded  to  adjuvant
radiotherapy  in  seven  cases  (87.5%  of  irradiated  patients),
while  one  patient  received  ﬁrst-line  radiotherapy  (#  5).
Chemotherapy  was  administered  to  four  patients.  Two
patients  (20%)  (#  5,  #  8)  received  cisplatin-based  chemother-
apy  concomitant  to  radiotherapy:  due  to  positive  surgical
margins  in  case  #  8  and  as  primary  treatment  in  patient  #
5,  who  was  not  treated  surgically.  One  patient  (10%)  was
treated  by  cisplatin  and  5-ﬂuorouracil  chemotherapy  fol-
lowed  by  paclitaxel  chemotherapy  after  radiotherapy  for  a
local  recurrence  (#  3)  and  one  patient  with  lung  metastases
was  treated  with  cisplatin  VP-16  (#  4).
The  mean  disease-free  survival  was  13.1  months  (±22.1)
with  a  5-year  disease-free  survival  rate  of  24%  (0.188)  all
stages  combined.  The  mean  5-year  overall  survival  was  18.7
months  (±22.2).  The  mean  overall  survival  was  62  months
for  early  stage  disease  (stage  I)  and  19.4  months  (±37.7)
for  advanced  stages  (III—IV).  The  mean  overall  survival  was
28.1  months  in  the  absence  of  peripheral  facial  nerve  palsy
versus  8.5  months  in  the  presence  of  peripheral  facial  nerve
palsy.  The  5-year  overall  survival  rate  was  35%  (±0.185)
all  stages  combined  according  to  the  Kaplan—Meier  method
(Fig.  2):  100%  early  stage  disease  (stage  I)  and  22.9%  (0.187)
for  advanced  stages  (III—IV).
c
a
cs  for  patients  with  carcinoma  of  the  external  auditory  canal
rvival  rate.
Four  patients  (#  2,  #  3,  #  7,  #  8)  presented  profound  post-
perative  hearing  loss  (50%  of  operated  patients).  Peripheral
acial  nerve  palsy  was  observed  in  ﬁve  patients  (#  2,  #  3,  #
,  #  7,  #  8)  (55.6%  of  treated  patients),  corresponding  to
rade  V  facial  nerve  palsy  of  the  House—Brackmann  score
or  three  patients  (#  2,  #  3,  #  4),  grade  IV  for  one  patient  (#
)  and  grade  III  for  one  patient  (#  7).  Delayed  healing  was
bserved  in  three  patients  (37.5%  of  operated  patients)  (#
,  #  7,  #  8)  in  whom  complete  resection  of  the  outer  ear  was
ecessary.
iscussion
ancer  of  the  EAC  is  a  rare  disease.  Several  case  series  have
een  reported  in  the  literature,  but  no  randomized  con-
rolled  study  has  yet  been  published.  The  mean  age  of  the
atients  in  the  present  study  was  61.5  years  with  a  sex  ratio
f  1,  as  described  in  the  literature  [2,6,7,10,11].
The  clinical  presentation  is  non-speciﬁc.  Otorrhoea  is  the
ost  common  symptom  and  may  be  suggestive  of  chronic
titis  externa  [7]. Otalgia  disproportionate  to  the  otoscopy
ndings  is  highly  suggestive  of  the  diagnosis  of  EAC  tumour,
articularly  adenoid  cystic  carcinoma  [12].  The  presence
f  peripheral  facial  nerve  palsy  is  a  major  clinical  ﬁnding,
s  it  suggests  a  locally  advanced  tumour  [13].  Facial  nerve
alsy  was  present  at  diagnosis  in  20%  of  cases  in  this  series,
 rate  comparable  to  that  reported  in  the  literature  [14].
wenty  percent  of  patients  had  a  history  of  multi-operated
holesteatoma  for  more  than  10  years.  Several  cases  of  squa-
ous  cell  carcinoma  of  the  EAC  secondary  to  cholesteatoma
ave  been  reported  in  the  literature  [15,16].  However,  the
ole  of  cholesteatoma  in  carcinoma  of  the  EAC  remains  con-
roversial,  as  some  authors  consider  cholesteatoma  to  be  a
isk  factor  for  carcinoma  of  the  EAC  [17], while  others  do
ot  [18].
In the  presence  of  non-speciﬁc  clinical  features  and
oubtful  otoscopic  ﬁndings  (especially  invasive  forms),
iopsy  must  be  performed,  preferably  in  the  operating  room
o  ensure  good  quality  biopsy  samples  for  histological  exam-
nation.Most  published  studies  have  concerned  squamous  cell
arcinoma,  which  is  the  most  common  histological  type  [19],
s  conﬁrmed  in  our  study  (70%).  No  cases  of  basal  cell  car-
inoma  of  the  EAC  were  observed  in  this  study,  although
180  K.  Ouaz  et  al.
Table  3  Survival  rates  for  carcinoma  of  the  external  auditory  canal  (EAC)  reported  in  the  literature.
Author  Sample  size  Types  Survival
Gurgel  et  al.,  2009  [29]  215  SCC  (62.8%)
ADC  (18.2%)
OC  (13%)
NCT  (6%)
Five-year
SCC  (23.9  %)
ADC  (65  %)
OC  (60  %)
NCT  (38.6  %)
Yin et  al.,  2006  [11]  95  SCC  (100%)  Five-year
Stage  I  et  II  (100%)
Stage  III  (67.2%)
Stage  IV  (29.5%)
Ogawa et  al.,  2007  [26]  87  SCC  (100%)  Five-year
55%  all  stages
Zhang et  al.,  1998  [27]  33  SCC  (100%)  Five-year
51.7%  all  stages
Stage  I  and  II  (100%)
Stage  III  (68.8%)
Stage  IV  (19.6%)
Moody et  al.,  2000  [1]  32  SCC  (100%)  Two-year
SCC  T1  (100  %)
SCC  T2  (80  %)
SCC  T3  (50  %)
SCC  T4  (7  %)
Pfreundner et  al.,  1999  [28]  27  SCC  (71.5%)
ADC  (9.5%)
OC  (19%)
Five-year
61  %  all  stages
T1  et  T2  (86  %)
T3 (50  %)
T4  (41  %)
Nakagawa  et  al.,  2006  [30]  12  SCC  (100%)  Five-year
SCC  T3  (85%)
SCC  T4  (35%)
Present study  2012  10  SCC  (60%)
OC  (20%)
ACC  (10%)
Five-year
35%  all  stages
Stage  III—IV  (22.9%)
SCC: squamous cell carcinoma; ADC: adenocarcinoma; OC: other carcinomas; NCT: other non-carcinomatous malignant tumours; BCC:
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cbasal cell carcinoma; ACC: adenoid cystic carcinoma.
t  constitutes  the  second  most  common  histological  type
ncountered.  No  studies  concerning  the  other  histological
ypes  have  been  published.
The  Pittsburgh  classiﬁcation,  based  on  clinical  and  radio-
ogical  ﬁndings,  is  used  for  TNM  staging  of  squamous
ell  carcinoma  of  the  EAC.  No  classiﬁcation  is  speciﬁcally
evoted  to  the  other  types.  Like  other  authors  [20,21],  we
xtrapolated  this  classiﬁcation  to  all  histological  types.  CT
can  allows  reliable  detection  of  bony  erosion  of  the  EAC
nd  invasion  of  the  facial  canal.  The  ﬁndings  of  preopera-
ive  CT  of  the  petrous  temporal  bones  are  correlated  with
istological  ﬁndings  [6].  In  our  study,  comparison  between
maging  and  histological  and  preoperative  ﬁndings  validated
he  use  of  this  classiﬁcation.  However,  there  are  a  num-
er  of  limitations  to  the  use  of  CT  for  evaluation  of  soft
issue  involvement  (parotid  and  infratemporal  fossa).  The
NM  staging  based  exclusively  on  CT  was  accurate  in  90%  of
ases  for  local  extension,  while  parotid  gland  invasion  was
a
t
tnly  demonstrated  by  MRI  in  10%  of  cases.  In  40%  of  cases,
RI  raised  the  suspicion  of  invasion  of  the  temporal  dura
ater  allowing  planned  dura  mater  resection.  Although  MRI
ndings  have  little  impact  on  the  TNM  staging  based  on  CT,
t  can  be  used  to  evaluate  parotid,  soft  tissue,  infratempo-
al  fossa  and  temporal  dura  mater  involvement  [6,22].  This
nformation  is  essential  for  the  management  of  invasive  EAC
umours,  especially  in  the  case  of  adenoid  cystic  carcinoma,
or  which  clinical  staging  assessment  is  particularly  difﬁcult.
hese  ﬁndings  therefore  suggest  that  MRI  should  be  system-
tically  performed  for  local  staging  of  carcinoma  of  the  EAC.
he  place  of  PET-CT  has  yet  to  be  deﬁned,  as  no  study  has
valuated  this  imaging  modality,  although  it  is  used  in  spe-
iﬁc  indications  for  squamous  cell  carcinomas  of  the  larynx
nd  hypopharynx.  No  study  has  been  published  concerning
he  use  of  PET-CT  in  malignant  tumours  of  the  EAC.
All  patients  in  this  series  were  treated  surgically  by  par-
ial  or  total  petrectomy  in  60%  of  cases.  Despite  extensive
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surgery,  the  resection  was  incomplete  in  more  than  one-
third  of  operated  patients  (37.5%),  which  is  comparable  to
the  data  of  the  literature  [21],  as  en  bloc  surgical  resection
comprising  safety  margins  is  difﬁcult  to  perform  in  the  small
bone  volume  of  the  petrous  apex.  Assessment  of  the  quality
of  resection  by  the  pathologist  is  complicated  by  resection
in  multiple  fragments.  Positive  surgical  margins  are  synony-
mous  with  progressive  disease  [23].  Progressive  disease  was
observed  in  one  half  of  cases,  leading  to  death  within  1  year
in  80%  of  cases.  A  low  lymph  node  invasion  rate  (20%)  was
observed  compared  to  the  high  rate  of  local  extension  (T4
in  60%  of  cases).  Distant  metastases  during  the  course  of
the  disease  were  observed  in  10%  of  cases.  Various  studies
[7,21]  suggest  that  early  aggressive  surgical  management  is
associated  with  improved  survival.  Some  authors  therefore
recommend  petrectomy  associated  with  en  bloc  superﬁcial
parotidectomy  for  squamous  cell  carcinoma  of  the  EAC  [21].
Facial  nerve  involvement  does  not  constitute  a  contraindica-
tion  to  surgical  management  [24].  In  the  presence  of  parotid
involvement,  with  tumour  adjacent  to  the  vertical  segment
of  the  facial  nerve,  the  patient  must  be  informed  about  the
possibility  of  facial  nerve  resection  and  postoperative  facial
palsy  [24].  Like  other  authors,  we  perform  limited  dura
mater  resection  when  this  tissue  is  invaded.  Dural  exten-
sion  does  not  appear  to  constitute  a  contraindication  to
surgery.  However,  surgery  is  contraindicated  in  the  presence
of  posterior  fossa,  middle  fossa,  or  internal  carotid  artery
involvement  [25].  Resections  did  not  exceed  2  cm2 in  the
present  series.
This  approach  was  conﬁrmed  by  the  conclusions  of  a
meta-analysis  [8]  based  on  26  publications  that  recom-
mended  subtotal  petrectomy  followed  by  external  beam
radiotherapy  in  the  presence  of  middle  ear  involvement.
However,  this  meta-analysis  also  concluded  on  the  absence
of  any  signiﬁcant  survival  difference  between  EAC  resection
and  subtotal  petrectomy  in  patients  with  tumours  conﬁned
to  the  EAC.
The  role  of  adjuvant  radiotherapy  remains  controversial,
as  no  study  has  formally  demonstrated  a  survival  bene-
ﬁt  [8,14].  Until  this  controversy  has  been  resolved,  we,
like  other  authors  [21,26],  continue  to  propose  adjuvant
radiotherapy.  Some  authors  suggest  that  small  lesions  with-
out  bony  erosion  can  be  treated  by  radiotherapy  alone
[8,13].  In  our  study,  10%  of  patients,  whose  general  status
was  not  compatible  with  surgery,  were  treated  by  ﬁrst-line
radiotherapy.  Conformal  radiotherapy  was  delivered  at  a
prophylactic  dose  of  50  Gy  and  a  curative  dose  of  70  Gy  in
the  presence  of  residual  tumour.
The  poor  5-year  overall  survival  rate  (35%  all  stages)
observed  in  this  series  can  be  explained  by  the  fact  that
most  patients  presented  advanced  disease  (stages  III  and
IV).  In  the  literature,  the  5-year  overall  survival  rate  ranges
from  80  to  100%  for  stages  I  and  II  carcinoma  of  the  EAC
[1,11,27]  and  from  50  to  20%  for  stages  III  and  IV  [1,11,28]
depending  on  the  series,  hence  the  importance  of  early
diagnosis.  The  present  series  comprised  a  smaller  propor-
tion  of  stages  I  and  II  tumours  compared  to  other  published
series  (33—54%)  [7,14].  The  5-year  overall  survival  rate  for
stages  III  and  IV  disease  was  22.9%,  comparable  to  the  rates
reported  in  the  literature  (Table  3).  This  lower  survival  rate
for  advanced  stages  conﬁrms  the  validity  of  the  Pittsburgh
classiﬁcation.181
Prognostic  factors  for  carcinoma  of  the  EAC  are  TNM
tage,  bony  erosion  of  the  EAC,  positive  surgical  margins,
xtratemporal  locoregional  invasion  (parotid,  cervical),
iddle  ear  involvement  and  the  presence  of  peripheral
acial  nerve  palsy  [6,7,21,24,31].  In  this  study,  the  mean
urvival  of  the  20%  of  patients  with  peripheral  facial  nerve
alsy  at  diagnosis  was  8.5  months  (7  and  10  months,  respec-
ively)  versus  28.13  months  in  the  absence  of  facial  nerve
alsy.  Middle  ear  involvement  corresponds  to  stage  III  of  the
ittsburgh  classiﬁcation.  Patients  presenting  retrotympanic
nvolvement  on  otoscopy  and/or  audiometric  abnormali-
ies  (often  related  to  middle  ear  involvement)  presented
 lower  survival,  thereby  validating  the  Pittsburgh  classiﬁ-
ation.  The  histological  type  also  constitutes  a  prognostic
actor.  Patients  with  basal  cell  carcinoma  had  a  better  sur-
ival  than  patients  with  other  histological  types.  Squamous
ell  carcinoma  of  the  EAC  is  the  most  common  histological
ype  and  is  associated  with  the  poorest  prognosis.
onclusion
ancer  of  the  EAC  is  a  difﬁcult  diagnosis  in  the  presence  of
hronic  otitis  externa  or  invasive  forms.  The  Pittsburgh  clas-
iﬁcation  has  been  validated  and  should  be  used  for  staging
f  these  tumours.  Clinical  examination  and  imaging  (CT  and
RI)  can  demonstrate  the  main  prognostic  factors:  periph-
ral  facial  nerve  palsy,  soft  tissue  (parotid)  involvement,
iddle  ear  involvement  and  lymph  node  involvement.  Man-
gement  consists  of  a  combination  of  radical  surgery  and
adiotherapy  and  the  prognosis  is  related  to  local  tumour
ontrol.  This  aggressive  treatment  is  almost  always  respon-
ible  for  sequelae.  Diagnosis  and  treatment  need  to  be
mproved  in  order  to  improve  patient  survival  associated
ith  fewer  sequelae.  Modern  imaging  techniques  (PET-CT
can)  and  new  radiotherapy  techniques  (cyberknife,  IMRT)
ust  be  evaluated.
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